Corporate | 8 May 2014 08:00
|
VERBIO Vereinigte BioEnergie AG / Key word(s): 9-month figures
VERBIO AG maintains positive business development and adjusts earnings forecast for financial year 2013/2014 again
* Biofuel production remains on a high level
Leipzig, May 8, 2014 – VERBIO AG announces that company expectations for the business performance to date and the future were exceeded in financial year 2013/2014. For the continuing operations of the Group, consolidated sales rose compared with the prior-year figure by 7.3 percent to EUR 573.1 million (9 M 2012/2013: EUR 534 million). This increase in sales is essentially demand-related. With 466,890 tons from July 2013 to March 2014, nearly 24 percent more biodiesel and bioethanol were produced than in the corresponding period of the previous year. The biomethane production from July 2013 to March 2014 amounted to 219,223 MWh. Meanwhile, the gross profit margin also improved by nearly 67 percent from EUR 32.4 million to EUR 54.0 million. Personnel expenses decreased by 6 percent amounting to EUR 16.5 million (9 M 2012/2013: EUR 17.5 million), other operating expenses decreased significantly by almost 22 percent, or EUR 4.9 million, to EUR 17.5 million compared to the previous year. As a result, earnings before interest, taxes, depreciation and amortization (EBITDA) rose significantly by EUR 29.7 million to EUR 28.9 million. Increased production and sales volumes as well as targeted cost reduction measures contributed to these improved earnings. Operating profit (EBIT) for the reporting period 2013/2014 was EUR 12.4 million (9 M 2012/2013: EUR -120.1 million). Consolidated earnings before taxes (EBT) for the reporting period were EUR 9.7 million (9 M 2012/2013: EUR -123.1 million), and net income for the period was EUR 8.7 million (9 M 2012/2013: -123.1 million). This resulted in (diluted/undiluted) earnings per share of EUR 0.14 (9 M 2012/2013: EUR -1.95).
The equity ratio increased further over the course of the financial year to a comfortable 59.3 percent (June 30, 2013: 43.4 percent). The sharp increase is mainly due to the reduction in total assets of nearly 23 percent from EUR 410.4 million (June 30, 2013) to EUR 317.1 million, essentially through the unscheduled repayment of short-term bank borrowing and other loans as well as the reduction of inventories.
With net debt of EUR 42.1 million, the ratio of net debt to EBITDA based on the total financial year 2013/2014 is clearly below two. As of the reporting date March 31, 2014, a cash balance resulted in the amount of EUR 16.9 million.
During reporting period 2013/2014, sales revenues in the biodiesel segment in the amount of EUR 360.9 million (9 M 2012/2013: EUR 329.9 million) were achieved. The cost of materials amounted to EUR 327.1 million, after EUR 308.2 million in the comparative period 2012/2013. Overall, the gross profit margin improved through increased sales and reduced pressure on margins clearly. Segment operating profit improved significantly from EUR -85.7 million in the comparative period 2012/2013 to EUR 15.4 million in the reporting period. In the previous year, segment operating income was negatively impacted by impairment losses in accordance with IAS 36 as well as book losses from the sale of biofuel quotas in the amount of EUR 88.0 million.
Continuous production increase in the bioethanol segment reflects increased demand; reduction of the selling prices for bioethanol strains segment result
Overall, sales revenues of EUR 197.4 million were announced for the bioethanol segment in the reporting period 2013/2014, after EUR 193.7 million (9 M 2012/2013). The cost of materials amounted to EUR 178.6 million (9 M 2012/2013: EUR 177.8 million). Despite lower sales prices for bioethanol in financial year 2013/2014 and a sideways movement of the raw materials required for production, the segment operating profit improved in the reporting period 2013/2014 from EUR -32.1 million by EUR 31.7 million to EUR -0.4 million. Segment earnings for the previous year were negatively impacted in the third quarter of 2012/2013 by impairment losses in accordance with IAS 36 as well as book losses from the sale of biofuel quota totaling EUR 25.1 million. Renewed increase in the earnings forecast for financial year 2013/2014 Due to the business development emerging for the remaining quarter, the Board has adjusted the earnings forecast for financial year 2013/2014 again. Accordingly, for continuing and discontinued operations in financial year 2013/2014, EBITDA of between EUR 36 million and EUR 40 million (previously: EUR 30 million to EUR 35 million) and EBIT in the range of EUR 10 million and EUR 14 million (previously: EUR 3 million to EUR 8 million) are expected. Detailed information about the business development from July 1, 2013 to March 31, 2014 can be found in the 9-Month Report 2013/2014, which is available at www.verbio.de .
Information about VERBIO Vereinigte BioEnergie AG (VERBIO)
Important notice
Contact: VERBIO Vereinigte BioEnergie AG Augustusplatz 9 04109 Leipzig Anna-Maria Schneider Investor Relations Phone: +49(0)341/308530-294 Fax: +49(0)341/308530-298 Email: ir@verbio.de/pr@verbio.de End of Corporate News 08.05.2014 Dissemination of a Corporate News, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
| Language: | English | |
| Company: | VERBIO Vereinigte BioEnergie AG | |
| Augustusplatz 9 | ||
| 04109 Leipzig | ||
| Germany | ||
| Phone: | +49 (0)341 308530-0 | |
| Fax: | +49 (0)341 308530-998 | |
| E-mail: | ir@verbio.de | |
| Internet: | www.verbio.de | |
| ISIN: | DE000A0JL9W6 | |
| WKN: | A0JL9W | |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart | |
| End of News | DGAP News-Service |
|
|
| 267106 08.05.2014 |